insufficient data
| T vs. C | paclitaxel followed by doxorubicin plus cyclophosphamide | pembrolizumab plus paclitxel followed by doxorubicin plus cyclophosphamide |
| paclitaxel followed by doxorubicin plus cyclophosphamide | --- | NA |
| pembrolizumab plus paclitxel followed by doxorubicin plus cyclophosphamide | NA | --- |
pathologies: 147
- treatments: 1071
result logic
